List view / Grid view
3 September 2015 | By Victoria White
AmpliPhi Biosciences Corporation has announced that Alexander Gaidamaka has been appointed as the new Vice President of Chemistry, Manufacturing and Control...
19 August 2015 | By Victoria White
AmpliPhi Biosciences Corporation has announced that its shares of common stock have been approved for listing on the NYSE MKT...
14 August 2015 | By Katie Sadler, Digital Content Producer, Drug Target Review
Biotechnology company, AmpliPhi Biosciences Corporation, released financial results for the second quarter 2015 and operational highlights. AmpliPhi, one of the leaders in the development of bacteriophage-based antibacterial therapies to treat antibiotic-resistant infections, has reported strong overall performance in overall liquidity and balance sheet strength thanks to a $13 million investment…
4 June 2015 | By Victoria White
AmpliPhi's production facility in Ljubljana has been cleared by JAZMP to manufacture bacteriophages under current Good Manufacturing Practices standards...
